ISSN |
2220-3206 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Psychiatry |
Manuscript Type |
Expert Consensus |
Article Title |
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement
|
Manuscript Source |
Invited Manuscript |
All Author List |
Susan Young, Cyrus Abbasian, Zainab Al-Attar, Polly Branney, Bill Colley, Samuele Cortese, Sally Cubbin, Quinton Deeley, Gisli Hannes Gudjonsson, Peter Hill, Jack Hollingdale, Steve Jenden, Joe Johnson, Deborah Judge, Alexandra Lewis, Peter Mason, Raja Mukherjee, David Nutt, Jane Roberts, Fiona Robinson, Emma Woodhouse and Kelly Cocallis |
Funding Agency and Grant Number |
|
Corresponding Author |
Susan Young, BSc, Doctor, PhD, Professor, Department of Psychology, Psychology Services Limited, PO 1735, Croydon CR9 7AE, United Kingdom. suzyyoung@aol.com |
Key Words |
Attention-deficit/hyperactivity disorder; Substance use; Pharmacokinetics; Assessment; Treatment; Comorbidity |
Core Tip |
Attention-deficit/hyperactivity disorder (ADHD) often co-occurs with substance use (SU) and/or substance use disorder (SUD). The co-occurrence of ADHD and SU/SUD is associated with earlier onset and faster transition to more serious SUD, and reduced treatment effectiveness. This manuscript is the product of a consensus meeting of experts from ADHD and/or SUD services, across a range of clinical, academic, educational, occupational, and service-user sectors. A consensus was reached offering practical guidance to support practitioners working with young people and adults with ADHD and SU/SUD with recommendations for identification and assessment, pharmacological treatment, psychological treatment, and multi-agency interventions. |
Publish Date |
2023-03-17 10:23 |
Citation |
Young S, Abbasian C, Al-Attar Z, Branney P, Colley B, Cortese S, Cubbin S, Deeley Q, Gudjonsson GH, Hill P, Hollingdale J, Jenden S, Johnson J, Judge D, Lewis A, Mason P, Mukherjee R, Nutt D, Roberts J, Robinson F, Woodhouse E, Cocallis K. Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: an expert consensus statement. World J Psychiatry 2023; 13(3): 84-112 |
URL |
https://www.wjgnet.com/2220-3206/full/v13/i3/84.htm |
DOI |
https://dx.doi.org/10.5498/wjp.v13.i3.84 |